Get Involved
On the day

Summit Therapeutics hits possible snag on lung cancer drug seen as a blockbuster

Posted:

Summit Therapeutics may have a geography problem with its lung cancer drug ivonescimab.

Ivonescimab produced weaker results in patients from North America and Europe than those from China.

Read more here.

 

Previous post
Back to list
Next post